The American Society of Clinical Oncology and Association of Community Cancer Centers are working to foster participation in cancer treatment trials to more fully reflect the diversity of people at risk for or living with cancer.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
